Parkinson’s disease, a neurological disorder characterized by the accumulation of a protein known as alpha-synuclein, may be influenced by the composition of gut bacteria. This debilitating condition manifests in motor function impairment, movement difficulties, muscle stiffness, and pronounced hand tremors. Annually, approximately 60,000 individuals in the United States receive a Parkinson’s diagnosis, while the global prevalence reaches up to 10 million people.
Studies and lab tests
Recent studies conducted by the California Institute of Technology have revealed that individuals with Parkinson’s disease possess significantly different gut microbiomes compared to those without the disease. This suggests that specific types of gut bacteria may contribute to the symptoms and severity of Parkinson’s.
To further investigate this connection, researchers at the institute conducted studies on mice. They genetically engineered the mice to develop Parkinson’s by increasing the levels of alpha-synuclein. Surprisingly, only half of the mice developed symptoms, and these symptoms were observed in the mice with gut bacteria present. In contrast, the mice without any gut bacteria remained symptom-free.
Additional experiments demonstrated that the symptoms of the mice worsened when they were injected with microbes extracted from human patients with Parkinson’s. However, no worsening of symptoms was observed when the mice were injected with samples from healthy individuals. These findings, along with previous laboratory studies, suggest that various microorganisms residing in the human body, including bacteria, yeast, fungi, and viruses, can influence the development and progression of various diseases.
Every individual harbors both beneficial and harmful bacteria in their digestive systems. The balance of these microbiomes directly affects a person’s overall health as they assist in the digestion of food. Specifically, gut bacteria break down dietary fiber into short-chain fatty acids, which then trigger chemical imbalances and activate immune cells in the brain, leading to damage. Scientists now believe that these bacteria release chemicals that excessively stimulate certain parts of the brain, resulting in further damage. Sarkis Mazmanian of the California Institute of Technology states, “Now we were quite confident that gut bacteria regulate, and are even required for, the symptoms of Parkinson’s disease.”
Dr. Arthur Roach from the Parkinson’s UK charity group also emphasizes the significance of this research by stating, “This work opens an exciting new avenue of study on the gut-brain connection in Parkinson’s.” While there is currently no cure for Parkinson’s disease and no antibiotic or microbial treatment available for humans that replicates the findings observed in mice, these scientists remain hopeful that their discoveries will be confirmed in human studies. This will ultimately facilitate the development of new drugs or probiotics to effectively treat individuals affected by Parkinson’s disease.